Logos Global Management LP Eledon Pharmaceuticals, Inc. Transaction History

Logos Global Management LP

  • $775 Million
  • Q2 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$3.06 - $4.89 $4.1 Million - $6.55 Million
-1,339,793 Closed
0 $0
Q2 2021

Aug 17, 2021
BUY
$7.62 - $11.75 $8.5 Million - $13.1 Million
1,115,722 Added 497.93%
1,339,793 $10.6 Million
Q1 2021

May 17, 2021
BUY
$9.85 - $19.22 $2.21 Million - $4.31 Million
224,071 New
224,071 $2.4 Million

Others Institutions Holding ELDN

# of Institutions
88
Shares Held
36.8M
Call Options Held
48.5K
Put Options Held
30.3K
View Full List

About Eledon Pharmaceuticals, Inc.

ELDN Quotes by TradingView
  • Ticker ELDN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,756,800
  • Market Cap $59.4M
  • Description
  • Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that i...
More about ELDN
Track This Portfolio

Track Logos Global Management LP Portfolio

Follow Logos Global Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Logos Global Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email